Compugen Ltd.
CGEN
$1.45
$0.021.40%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/10/2025
-
MarketBeat
8/8/2025
-
Seeking Alpha - Long Ideas
8/8/2025
-
Seeking Alpha - Israel Stocks
8/8/2025
-
SeekingAlpha
8/7/2025
-
The Fly
8/7/2025
-
Seeking Alpha - Israel Stocks
8/7/2025
-
SeekingAlpha
8/7/2025
-
Seeking Alpha: Transcripts
8/7/2025
-
Seeking Alpha - Israel Stocks
8/7/2025
-
GuruFocus
8/6/2025
-
GuruFocus
8/6/2025
-
Zacks Investment Research
8/6/2025
-
GuruFocus
8/6/2025
-
The Fly
8/6/2025
-
Seeking Alpha - Israel Stocks
8/6/2025
-
PR Newswire
8/5/2025
-
SeekingAlpha.com: All News
7/28/2025
-
GuruFocus
7/28/2025
-
GuruFocus
7/28/2025
-
PR Newswire
7/23/2025
-
GuruFocus
7/23/2025
-
GuruFocus
7/23/2025
-
PR Newswire
7/21/2025
-
GuruFocus
7/21/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Wednesday, August 6, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 765 8585
Address
Azrieli Center
Building D - 26 Harokmim Street
Holon, 5885849
Building D - 26 Harokmim Street
Holon, 5885849
Country
Year Founded
Business Description
Sector
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the...
more